Citius Pharmaceuticals Inc (CTXR) financials · $13.4M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Citius Pharmaceuticals Inc (CTXR) $13.4M cap.
| Line | Q3 2026 | Q2 2026 |
|---|---|---|
| Revenue | $1.49M | $1.67M |
| Cost of Revenue | $491.8K | $328.9K |
| Gross Profit | $1.00M | $1.34M |
| Operating Income | -$11.7M | -$32.2M |
| Net Income | -$11.9M | -$28.1M |
| EPS (Diluted) | -$0.34 | -$0.95 |
| Line | Q3 2026 | Q2 2026 |
|---|---|---|
| Total Assets | $142.3M | $132.5M |
| Current Assets | $43.3M | $31.7M |
| Cash & Equivalents | $17.0M | $4.59M |
| Inventory | $22.6M | $22.7M |
| Total Liabilities | $66.3M | $63.5M |
| Current Liabilities | $51.6M | $55.0M |
| Shareholders' Equity | $66.6M | $61.5M |
| Retained Earnings | -$277.1M | -$268.3M |
| Line | FY2024 | FY2023 |
|---|---|---|
| Operating Cash Flow | -$28.2M | -$29.1M |
| Investing Cash Flow | -$5.00M | N/A |
| Financing Cash Flow | $9.97M | $13.8M |
FAQ
What is CTXR P/E and revenue?
Citius Pharmaceuticals Inc (CTXR) $13.4M cap.
What is CTXR revenue?
Citius Pharmaceuticals Inc last cached revenue is $1.49M (Q3 2026).
Is CTXR profitable?
Citius Pharmaceuticals Inc last cached net income is -$11.9M (Q3 2026).
What are CTXR total assets?
Citius Pharmaceuticals Inc last cached total assets are $142.3M (Q3 2026).
What is CTXR free cash flow?
No cached cash-flow row for CTXR yet.
Not investment advice. Cached statements, not a live tape.